Michel Levy
President and Chief Executive Officer
ADDS (Advanced Drug Development Services)
France
Biography
Michel has an experience of more than 27 years in the Pharmaceutical industry where he held leadership positions as European Clinical Research Director for Parke-Davis (Pfizer), Medical Director for Wyeth and Zeneca as well as VP Medical Affairs for Beaufour Ipsen. After taking the management of the European R&D Operations of GENTA Inc.; a Californian Biotech company specialized on oligonucleotide antisense technology, Dr. Levy founded in 1995 Advanced Drug Development Services which has became an European CRO specialized in clinical trials. Michel is doctor in Medicine with a Master degree in Pharmacology and he is an INSEAD graduate. Currently Michel is member of the board of AMIPS (The French association of medical doctors working with health products companies) and is Vice-President of AFCROs (the French association of CROs)
Research Interest
Clinical Research
